Market Cap (In CAD)
53.08 Million
Revenue (In CAD)
13.65 Million
Net Income (In CAD)
-4.7 Million
Avg. Volume
71.63 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.18-0.34
- PE
- -
- EPS
- -
- Beta Value
- 2.96
- ISIN
- CA45783P1027
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Iris Bincovich
- Employee Count
- -
- Website
- https://innocanpharma.com
- Ipo Date
- 2019-09-25
- Details
- InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.
More Stocks
-
SEALMATICSealmatic India Limited
SEALMATIC
-
VHL
-
IZO
-
ARISE
-
CEMATCemat A/S
CEMAT
-
002258Lier Chemical Co.,LTD.
002258
-
COSYNCosyn Limited
COSYN
-
GWSO